About the department
Novo Nordisk Korea has established a strong foothold as a market leader which has offered best solutions for people with diabetes, obesity, haemophilia and growth hormones disorder for more than 30 years. The affiliate has been delivering double digit sales growth year-on-year. Our sales growth stands-out in the market and within Novo Nordisk. The affiliate is ranked among the top 15 within Novo Nordisk in term of total revenue generated. With our CMR Ambition (“Strive for Quality of Life for Everyone”), we have strived to accelerate business growth, optimize organizational excellence, and attract and retain the best talents.It is an exciting time to join Novo Nordisk and achieve our strategic aspirations to establish global presence in the treatment of MASH. We’re a dynamic company in an even more dynamic industry, and we know that what got us to where we are today is not necessarily what will make us successful in the future.

In Other Serious Chronic Diseases (OSCD), we aim to create a strong presence by building a competitive pipeline and scientific leadership. Our focus will be on Metabolic dysfunction Associated Steatohepatitis (MASH) and New Therapy Areas such as chronic kidney disease (CKD), cardiovascular (CVD), inflammation and Alzheimer’s disease. The positionAs a Medical Advisor, you will be part of the CMR (Clinical, Medical and Regulatory) department, partnering with other departments to develop and execute MASH medical affairs strategy, build advocacy, build competencies and drive the setup of MASH New therapeutic Area. You will report to the Head of Medical Affairs, Korea.

The key responsibilities include (but are not limited to):

• Responsible for the planning and execution of the local medical strategy for development of the MASH therapy area. You will be instrumental in the identification and segmentation of KOLs relevant to the MASH therapy area and develop engagement plans, including obtaining expert advice to guide local decisions and strategy.
• Draft and adapt a global publication plan with regard to the local needs and regulations. You will also liaise with relevant professional associations, including congress activities in support of Novo Nordisk’s presence in the MASH area. 
• Provide guidance and training internally to support capability building in affiliate as well as giving support to clinical operations in the execution of clinical trials in MASH, in geographies where medical resources to support MASH studies are not available are also key responsibilities. 
• Seek opportunities and advice to obtain understanding of the market and patient pathways within MASH in support of internal medical and commercial business decisions and scientific development of MASH area.
• Close collaboration with medical and commercial colleagues in obesity to ensure strategic alignment and synergy of MASH within obesity is key to success.

[자격요건]

• MD, Ph.D., Pharm D or Pharmacist with experience in the field of metabolic medicine (diabetes, obesity, CVD, dyslipidaemia) preferably, either from the pharmaceutical industry, medical practice or academia. 
• A minimum of 6 years’ experience in medical affairs in the pharmaceutical industry would be mandatory and have an in-depth understanding of the role of medical affairs in pharmaceutical industry, medical affairs tools and activities. 
• You can connect medical affairs and commercial priorities and can work with cross-functional stakeholders. You have excellent medical communication skills. You are driven, can take initiative, and are agile in actions.
• The position requires a relatively moderate to high level (around 30%) of travelling within the country and abroad.
• You are fluent in both written and spoken English and Korean languages. Knowledge and experience of the local Korean market is a priority.